A new study published in the journal Neuron suggests that a new vaccine can slow the progression of Alzheimer's disease. The vaccine, initially deemed a failure after patients developed severe side effects, causes the body to produce antibodies that attack a protein believed to cause the brain damage found in Alzheimer's patients. Hear NPR's Jon Hamilton.
Copyright 2003 NPR
This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.
We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.
Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play.
